Fielmann Aktiengesellschaft (FIE.DE)
EUR 52.5
(5.0%)
EUR 52.5
(5.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.96 Billion EUR | 11.92% |
| 2022 | 1.75 Billion EUR | 4.84% |
| 2021 | 1.67 Billion EUR | 17.44% |
| 2020 | 1.42 Billion EUR | -6.04% |
| 2019 | 1.52 Billion EUR | 6.49% |
| 2018 | 1.42 Billion EUR | 3.03% |
| 2017 | 1.38 Billion EUR | 3.65% |
| 2016 | 1.33 Billion EUR | 2.86% |
| 2015 | 1.29 Billion EUR | 5.99% |
| 2014 | 1.22 Billion EUR | 6.0% |
| 2013 | 1.15 Billion EUR | 4.52% |
| 2012 | 1.1 Billion EUR | 5.09% |
| 2011 | 1.05 Billion EUR | 5.96% |
| 2010 | 994.22 Million EUR | 4.38% |
| 2009 | 952.49 Million EUR | 5.52% |
| 2008 | 902.67 Million EUR | 7.57% |
| 2007 | 839.18 Million EUR | 5.84% |
| 2006 | 792.91 Million EUR | 8.16% |
| 2005 | 733.07 Million EUR | 13.28% |
| 2004 | 647.14 Million EUR | -21.24% |
| 2003 | 821.69 Million EUR | 24.77% |
| 2002 | 658.58 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 552.69 Million EUR | 4.46% |
| 2024 Q1 | 529.11 Million EUR | 12.16% |
| 2023 Q4 | 471.74 Million EUR | -10.39% |
| 2023 Q3 | 526.43 Million EUR | 6.74% |
| 2023 Q2 | 493.21 Million EUR | 3.25% |
| 2023 FY | 1.96 Billion EUR | 11.92% |
| 2023 Q1 | 477.69 Million EUR | 8.06% |
| 2022 Q3 | 462.66 Million EUR | 5.12% |
| 2022 FY | 1.75 Billion EUR | 4.84% |
| 2022 Q2 | 440.11 Million EUR | 6.2% |
| 2022 Q1 | 414.42 Million EUR | -3.11% |
| 2022 Q4 | 442.08 Million EUR | -4.45% |
| 2021 Q4 | 427.72 Million EUR | -7.18% |
| 2021 FY | 1.67 Billion EUR | 17.44% |
| 2021 Q1 | 381.98 Million EUR | -3.81% |
| 2021 Q2 | 407.65 Million EUR | 6.72% |
| 2021 Q3 | 460.78 Million EUR | 13.03% |
| 2020 Q1 | 355.26 Million EUR | -68.3% |
| 2020 Q2 | 255.58 Million EUR | -28.06% |
| 2020 Q3 | 420.99 Million EUR | 64.72% |
| 2020 FY | 1.42 Billion EUR | -6.04% |
| 2020 Q4 | 397.09 Million EUR | -5.68% |
| 2019 Q3 | 400.05 Million EUR | 3.52% |
| 2019 Q2 | 386.43 Million EUR | 3.95% |
| 2019 Q1 | 371.75 Million EUR | 6.17% |
| 2019 FY | 1.52 Billion EUR | 6.49% |
| 2019 Q4 | 1.12 Billion EUR | 180.13% |
| 2018 Q1 | 349.85 Million EUR | 7.29% |
| 2018 FY | 1.42 Billion EUR | 3.03% |
| 2018 Q2 | 361.62 Million EUR | 3.37% |
| 2018 Q3 | 366.35 Million EUR | 1.31% |
| 2018 Q4 | 350.17 Million EUR | -4.42% |
| 2017 Q2 | 353.48 Million EUR | 3.4% |
| 2017 Q3 | 364.54 Million EUR | 3.13% |
| 2017 Q4 | 326.07 Million EUR | -10.55% |
| 2017 Q1 | 341.87 Million EUR | 4.27% |
| 2017 FY | 1.38 Billion EUR | 3.65% |
| 2016 Q4 | 327.85 Million EUR | -6.04% |
| 2016 Q3 | 348.94 Million EUR | 1.44% |
| 2016 Q2 | 344 Million EUR | 8.74% |
| 2016 Q1 | 316.36 Million EUR | 0.98% |
| 2016 FY | 1.33 Billion EUR | 2.86% |
| 2015 Q2 | 327.22 Million EUR | 3.19% |
| 2015 Q4 | 313.28 Million EUR | -8.48% |
| 2015 Q3 | 342.32 Million EUR | 4.61% |
| 2015 FY | 1.29 Billion EUR | 5.99% |
| 2015 Q1 | 317.1 Million EUR | 7.42% |
| 2014 Q2 | 306.64 Million EUR | 0.1% |
| 2014 Q3 | 318.3 Million EUR | 3.8% |
| 2014 Q4 | 295.19 Million EUR | -7.26% |
| 2014 FY | 1.22 Billion EUR | 6.0% |
| 2014 Q1 | 306.34 Million EUR | 8.18% |
| 2013 Q3 | 302 Million EUR | 2.69% |
| 2013 Q1 | 277.8 Million EUR | 2.73% |
| 2013 FY | 1.15 Billion EUR | 4.52% |
| 2013 Q4 | 283.18 Million EUR | -6.23% |
| 2013 Q2 | 294.1 Million EUR | 5.87% |
| 2012 FY | 1.1 Billion EUR | 5.09% |
| 2012 Q1 | 271.49 Million EUR | 5.38% |
| 2012 Q2 | 279.59 Million EUR | 2.98% |
| 2012 Q3 | 285.55 Million EUR | 2.13% |
| 2012 Q4 | 270.43 Million EUR | -5.3% |
| 2011 Q3 | 272.13 Million EUR | 1.53% |
| 2011 Q2 | 268.03 Million EUR | 2.82% |
| 2011 Q1 | 260.67 Million EUR | 7.37% |
| 2011 FY | 1.05 Billion EUR | 5.96% |
| 2011 Q4 | 257.63 Million EUR | -5.33% |
| 2010 FY | 994.22 Million EUR | 4.38% |
| 2010 Q4 | 242.77 Million EUR | -6.38% |
| 2010 Q3 | 259.32 Million EUR | 3.61% |
| 2010 Q2 | 250.28 Million EUR | 5.55% |
| 2010 Q1 | 237.12 Million EUR | 0.55% |
| 2009 Q1 | 226.33 Million EUR | 0.0% |
| 2009 Q2 | 238.18 Million EUR | 5.24% |
| 2009 Q4 | 235.82 Million EUR | -4.45% |
| 2009 FY | 952.49 Million EUR | 5.52% |
| 2009 Q3 | 246.79 Million EUR | 3.61% |
| 2008 FY | 902.67 Million EUR | 7.57% |
| 2007 FY | 839.18 Million EUR | 5.84% |
| 2006 FY | 792.91 Million EUR | 8.16% |
| 2005 FY | 733.07 Million EUR | 13.28% |
| 2004 FY | 647.14 Million EUR | -21.24% |
| 2003 FY | 821.69 Million EUR | 24.77% |
| 2002 FY | 658.58 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 898.6 Million EUR | -119.127% |
| Carl Zeiss Meditec AG | 2.08 Billion EUR | 5.754% |
| Gerresheimer AG | 1.99 Billion EUR | 1.075% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 42.013% |
| Sartorius Aktiengesellschaft | 3.39 Billion EUR | 42.013% |